GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Spire Healthcare Group SPI.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

248.00p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Spire Healthcare Group

Its shares trade on LSE under the ticker SPI.L. It has been listed since 18 July 2014. In the fiscal year to 31 December 2025, it reported revenue of £1.58bn and net income of £16.4m. At that date it held total assets of £2.38bn and shareholders' equity of £742.8m.

Spire Healthcare Group Plc operates as a private hospital group, which offers diagnostics, in-patient daycase and out-patient care procedures in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery and also diagnostic services including imaging and pathology, as well as out-patient services, such as consulting, minor procedures, treatments, health checks and physiotherapy. The firm operates approximately 39 hospitals and over 8 clinics across the United Kingdom. The firm also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The firm offers a range of primary care, consulting and diagnostic services. The firm's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The firm's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
18 Jul 2014
Employees
11,439

Leadership

Pay as last reported

  • Sir Ian CheshireNon-Executive Chairman of the Board, since 2021£240,400
  • Mr. Justinian AshChief Executive Officer, Executive Director, since 2017£1.8m
  • Sir David SlomanNon-Executive Vice Chairman of the Board
  • Mr. Harbant SamraChief Financial Officer, Executive Director, since 2024£484,200
  • Mr. Derrick FarrellChief Executive Officer - Vita Health Group
  • Mr. John ForrestChief Operating Officer
  • Mr. Mantraraj BudhdevGroup General Counsel, Company Secretary, Corporate Concerns Director
  • Ms. Rachel KingGroup People Director
  • Dr. Cathy CaleGroup Medical Director
  • Mr. Peter CorfieldChief Commercial Officer
  • Prof. Lisa GrantGroup Clinical Director, Chief Nurse
  • Dr. Ronnie van Der MerweNon-Executive Director£60,300

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
60
Environment
72
Social
39
Governance
69
Direct emissions (scope 1)
14,528 t
Energy emissions (scope 2)
11,903 t
Value chain emissions (scope 3)
325,772 t
Women in the workforce
59.34535%
Carbon reduction policy
Yes
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.